Knight Therapeutics' Analyst Update
Monday, October 21, 2019
08:30 AM EDT
Jonathan Goodman, Knight’s CEO Samira Sakhia, President and CFO Amal Khouri, VP, Business Development
If you have previously registered for this event, please login below:
Registration is required to attend this event. Please register now.
Please enable Cookies in your browser before registering for the webcast.